Taxus stents don't increase later clot risk, trial shows

09/4/2007 | Forbes

Boston Scientific Corp. has released the five-year and final results of clinical trials for the Taxus drug-coated stent that show no evidence of increased risk of blood clots in patients between years four and five following the implant.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA